METABOLIC & WEIGHT LOSS STACK
AOD9604 + CJC-1295 (No DAC)Lipolytic GH fragment + GHRH
Synergy: AOD9604 is the GH fragment 176-191 that targets fat metabolism without elevating IGF-1. Pairing with CJC-1295 no DAC adds endogenous GH elevation, broadening the metabolic effect.
Stack components
AOD9604
Metabolic & Weight
GH fragment 176-191 targeting fat metabolism without IGF-1. Enter target dose, get exact IU draw.
300 µg draw on 100u syringe
CJC-1295 (No DAC)
Growth Hormone
Modified GRF 1-29, a short-acting GHRH analog often stacked with Ipamorelin.
100 µg draw on 100u syringe
Injection timing
AOD9604: SC daily AM. CJC-1295: SC before bed.
Same syringe or separate?
Different times of day; not combined.
Typical cycle length
8 to 12 weeks.
Research use only. Peptide stacks compound effects and side-effect risk. Always verify Certificates of Analysis for each peptide. Consult a qualified clinician before initiating any combined protocol.
Open the calculators
Frequently asked
What does the AOD9604 + CJC-1295 (No DAC) stack do?
AOD9604 is the GH fragment 176-191 that targets fat metabolism without elevating IGF-1. Pairing with CJC-1295 no DAC adds endogenous GH elevation, broadening the metabolic effect.
When should AOD9604 and CJC-1295 (No DAC) be injected?
AOD9604: SC daily AM. CJC-1295: SC before bed.
Can AOD9604 and CJC-1295 (No DAC) be drawn into the same syringe?
Different times of day; not combined.
How long is a typical AOD9604 + CJC-1295 (No DAC) cycle?
8 to 12 weeks.
What dose of AOD9604 pairs with CJC-1295 (No DAC)?
Standard ASCEND reference dose for AOD9604: 300 µg from a 5 mg vial reconstituted with 1 mL bacteriostatic water (5000 µg/mL). Draw volume at this concentration: 0.06 mL, which is 6 IU on a 100-unit insulin syringe. Adjust to the research protocol you are following.
Related
For research informational use only. Not medical advice. Combination protocols have not been formally validated by the FDA. Consult a qualified healthcare provider before initiating any peptide stack.